Amiodarone. Therapeutics and guidelines.
Amiodarone, a newly marketed Type III antiarrhythmic, is indicated in the treatment of life-threatening ventricular dysrhythmias, including sustained ventricular tachycardia and ventricular fibrillation. Nurses who specialize in the treatment of cardiac patients should familiarize themselves with the general pharmacology of amiodarone. Specifically, nurses should be knowledgable of the considerable side effects of amiodarone and be able to translate to their patients pertinent information about prevention, detection, and management of potential side effects.
Frei
J
J
D000638:Amiodarone / Q000009:adverse effects / Q000627:therapeutic use*; D004347:Drug Interactions; D006801:Humans; D013610:Tachycardia / Q000188:drug therapy* / Q000451:nursing; D014693:Ventricular Fibrillation / Q000188:drug therapy* / Q000451:nursing
D000638:Amiodarone